Jelena Lukovic, J John Kim, Zhihui Amy Liu, Bernard J Cummings, James D Brierley, Rebecca K S Wong, Jolie G Ringash, Laura A Dawson, Aisling Barry, Monika K Krzyzanowska, Eric X Chen, David W Hedley, Fayez A Quereshy, Carol J Swallow, Robert N Gryfe, Erin D Kennedy, Alexandra M Easson, Ali Hosni
BACKGROUND: Anal adenocarcinoma is a rare clinical entity for which the optimal management is not defined. OBJECTIVE: This study aimed to describe the multidisciplinary management and outcomes of patients with anal adenocarcinoma. DESIGN: This is a retrospective cohort study. SETTING: This study was conducted at a quaternary cancer center. PATIENTS: Men and women with anal adenocarcinoma treated between 1995 and 2016 were selected...
February 1, 2022: Diseases of the Colon and Rectum